top of page

Blog
NDR White Paper Issue 6: Energy Metabolism
NDR is approaching ALS from multiple directions- in 2021 we have 17 active projects! What is fascinating is the emerging overlap between...
Nov 5, 20204 min read
Â
Â
NDR White Paper Issue 5: Activity of Thymosan
Immunonormalizing molecules thymopoietin and levamisole HCl Inflammation and regulation of inflammatory responses are necessary for life....
Aug 28, 20203 min read
Â
Â
NDR White Paper Issue 4: C9orf72
RAN Proteins The discovery of a repeat expansion1 in the C9orf72 gene is important because it is a model to explain central...
Aug 4, 20204 min read
Â
Â
NDR White Paper Issue 2: Treatments Are Lacking
NDR’s goals are simple, bring promising therapies to ALS patients and know which treatment is appropriate for a patient by evaluating...
May 7, 20204 min read
Â
Â
NDR White Paper Issue 1: Thymopoietin
Amyotrophic lateral sclerosis (ALS) is a motor neuron disease of animals and man with life-altering consequences. The defining pathology...
May 1, 20203 min read
Â
Â
bottom of page